1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Anti-inflammatory Biologics 1.2.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs) 1.2.4 Corticosteroids 1.3 Market by Application 1.3.1 Global Inflammatory Bowel Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Use 1.3.3 Home Use 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Inflammatory Bowel Disease Therapeutics Market Perspective (2016-2027) 2.2 Inflammatory Bowel Disease Therapeutics Growth Trends by Regions 2.2.1 Inflammatory Bowel Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Inflammatory Bowel Disease Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Inflammatory Bowel Disease Therapeutics Industry Dynamic 2.3.1 Inflammatory Bowel Disease Therapeutics Market Trends 2.3.2 Inflammatory Bowel Disease Therapeutics Market Drivers 2.3.3 Inflammatory Bowel Disease Therapeutics Market Challenges 2.3.4 Inflammatory Bowel Disease Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Revenue 3.1.1 Global Top Inflammatory Bowel Disease Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Inflammatory Bowel Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapeutics Revenue 3.4 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio 3.4.1 Global Inflammatory Bowel Disease Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapeutics Revenue in 2020 3.5 Inflammatory Bowel Disease Therapeutics Key Players Head office and Area Served 3.6 Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service 3.7 Date of Enter into Inflammatory Bowel Disease Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Inflammatory Bowel Disease Therapeutics Breakdown Data by Type 4.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Type (2022-2027) 5 Inflammatory Bowel Disease Therapeutics Breakdown Data by Application 5.1 Global Inflammatory Bowel Disease Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Inflammatory Bowel Disease Therapeutics Market Size (2016-2027) 6.2 North America Inflammatory Bowel Disease Therapeutics Market Size by Type 6.2.1 North America Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2027) 6.3 North America Inflammatory Bowel Disease Therapeutics Market Size by Application 6.3.1 North America Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2027) 6.4 North America Inflammatory Bowel Disease Therapeutics Market Size by Country 6.4.1 North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Inflammatory Bowel Disease Therapeutics Market Size (2016-2027) 7.2 Europe Inflammatory Bowel Disease Therapeutics Market Size by Type 7.2.1 Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2027) 7.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Application 7.3.1 Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2027) 7.4 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country 7.4.1 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Type 8.2.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Application 8.3.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region 8.4.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Inflammatory Bowel Disease Therapeutics Market Size (2016-2027) 9.2 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Type 9.2.1 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Application 9.3.1 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country 9.4.1 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type 10.2.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application 10.3.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country 10.4.1 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbvie 11.1.1 Abbvie Company Details 11.1.2 Abbvie Business Overview 11.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Introduction 11.1.4 Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) 11.1.5 Abbvie Recent Development 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Details 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Introduction 11.2.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) 11.2.5 Johnson & Johnson Recent Development 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 GlaxoSmithKline Business Overview 11.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Introduction 11.3.4 GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) 11.3.5 GlaxoSmithKline Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Inflammatory Bowel Disease Therapeutics Introduction 11.4.4 Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) 11.4.5 Merck Recent Development 11.5 Novartis 11.5.1 Novartis Company Details 11.5.2 Novartis Business Overview 11.5.3 Novartis Inflammatory Bowel Disease Therapeutics Introduction 11.5.4 Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) 11.5.5 Novartis Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Inflammatory Bowel Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Anti-inflammatory Biologics Table 3. Key Players of Non-Steroidal Anti-inflammatory drugs (NSAIDs) Table 4. Key Players of Corticosteroids Table 5. Global Inflammatory Bowel Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Inflammatory Bowel Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Inflammatory Bowel Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions (2016-2021) Table 9. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions (2022-2027) Table 11. Inflammatory Bowel Disease Therapeutics Market Trends Table 12. Inflammatory Bowel Disease Therapeutics Market Drivers Table 13. Inflammatory Bowel Disease Therapeutics Market Challenges Table 14. Inflammatory Bowel Disease Therapeutics Market Restraints Table 15. Global Inflammatory Bowel Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Inflammatory Bowel Disease Therapeutics Market Share by Players (2016-2021) Table 17. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2020) Table 18. Ranking of Global Top Inflammatory Bowel Disease Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Inflammatory Bowel Disease Therapeutics Product Solution and Service Table 22. Date of Enter into Inflammatory Bowel Disease Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Inflammatory Bowel Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global Inflammatory Bowel Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Abbvie Company Details Table 63. Abbvie Business Overview Table 64. Abbvie Inflammatory Bowel Disease Therapeutics Product Table 65. Abbvie Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) & (US$ Million) Table 66. Abbvie Recent Development Table 67. Johnson & Johnson Company Details Table 68. Johnson & Johnson Business Overview Table 69. Johnson & Johnson Inflammatory Bowel Disease Therapeutics Product Table 70. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) & (US$ Million) Table 71. Johnson & Johnson Recent Development Table 72. GlaxoSmithKline Company Details Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Product Table 75. GlaxoSmithKline Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) & (US$ Million) Table 76. GlaxoSmithKline Recent Development Table 77. Merck Company Details Table 78. Merck Business Overview Table 79. Merck Inflammatory Bowel Disease Therapeutics Product Table 80. Merck Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) & (US$ Million) Table 81. Merck Recent Development Table 82. Novartis Company Details Table 83. Novartis Business Overview Table 84. Novartis Inflammatory Bowel Disease Therapeutics Product Table 85. Novartis Revenue in Inflammatory Bowel Disease Therapeutics Business (2016-2021) & (US$ Million) Table 86. Novartis Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Inflammatory Bowel Disease Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Anti-inflammatory Biologics Features Figure 3. Non-Steroidal Anti-inflammatory drugs (NSAIDs) Features Figure 4. Corticosteroids Features Figure 5. Global Inflammatory Bowel Disease Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Hospital Use Case Studies Figure 7. Home Use Case Studies Figure 8. Inflammatory Bowel Disease Therapeutics Report Years Considered Figure 9. Global Inflammatory Bowel Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Inflammatory Bowel Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions: 2020 VS 2027 Figure 12. Global Inflammatory Bowel Disease Therapeutics Market Share by Regions (2022-2027) Figure 13. Global Inflammatory Bowel Disease Therapeutics Market Share by Players in 2020 Figure 14. Global Top Inflammatory Bowel Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapeutics as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapeutics Revenue in 2020 Figure 16. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2016-2021) Figure 17. Global Inflammatory Bowel Disease Therapeutics Revenue Market Share by Type (2022-2027) Figure 18. North America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Inflammatory Bowel Disease Therapeutics Market Share by Type (2016-2027) Figure 20. North America Inflammatory Bowel Disease Therapeutics Market Share by Application (2016-2027) Figure 21. North America Inflammatory Bowel Disease Therapeutics Market Share by Country (2016-2027) Figure 22. United States Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Inflammatory Bowel Disease Therapeutics Market Share by Type (2016-2027) Figure 26. Europe Inflammatory Bowel Disease Therapeutics Market Share by Application (2016-2027) Figure 27. Europe Inflammatory Bowel Disease Therapeutics Market Share by Country (2016-2027) Figure 28. Germany Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Share by Type (2016-2027) Figure 36. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Share by Application (2016-2027) Figure 37. Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Share by Region (2016-2027) Figure 38. China Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Inflammatory Bowel Disease Therapeutics Market Share by Type (2016-2027) Figure 46. Latin America Inflammatory Bowel Disease Therapeutics Market Share by Application (2016-2027) Figure 47. Latin America Inflammatory Bowel Disease Therapeutics Market Share by Country (2016-2027) Figure 48. Mexico Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Share by Type (2016-2027) Figure 52. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Share by Application (2016-2027) Figure 53. Middle East & Africa Inflammatory Bowel Disease Therapeutics Market Share by Country (2016-2027) Figure 54. Turkey Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Inflammatory Bowel Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Abbvie Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2016-2021) Figure 58. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2016-2021) Figure 59. GlaxoSmithKline Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2016-2021) Figure 60. Merck Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2016-2021) Figure 61. Novartis Revenue Growth Rate in Inflammatory Bowel Disease Therapeutics Business (2016-2021) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Abbvie Johnson & Johnson GlaxoSmithKline Merck Novartis